Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Classic Hodgkin Lymphoma”

243 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 243 results

Testing effectiveness (Phase 2)Study completedNCT01569204
What this trial is testing

Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Cologne 100
Not applicableStudy completedNCT00305149
What this trial is testing

Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin LymphomaNodular SclerosisMixed Cellularity+2 more
Rambam Health Care Campus 130
Testing effectiveness (Phase 2)Looking for participantsNCT05723055
What this trial is testing

Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Utah 9
Testing effectiveness (Phase 2)Study completedNCT03114683
What this trial is testing

Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma

Who this might be right for
Relapsed/Refractory Classical Hodgkin's Lymphoma
Innovent Biologics (Suzhou) Co. Ltd. 96
Testing effectiveness (Phase 2)Study completedNCT01169636
What this trial is testing

Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma

Who this might be right for
Hodgkin's Lymphoma
M.D. Anderson Cancer Center 62
Very early researchActive Not RecruitingNCT04134325
What this trial is testing

Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma

Who this might be right for
Relapsed Hodgkin LymphomaRefractory Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer Center 10
Large-scale testing (Phase 3)UnknownNCT04342936
What this trial is testing

Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Jiangsu HengRui Medicine Co., Ltd. 56
Not applicableStudy completedNCT01459224
What this trial is testing

MELT - MRI Evaluation of Lymphoma Treatment

Who this might be right for
Lymphoma, Hodgkin
University College, London 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT03749018
What this trial is testing

Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Aggressive Non-Hodgkin LymphomaAnn Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell LymphomaAnn Arbor Stage II B-Cell Non-Hodgkin Lymphoma+11 more
David Bond, MD 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04938232
What this trial is testing

Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL

Who this might be right for
Hodgkin LymphomaRelapsed Hodgkin's Disease, AdultRefractory Hodgkin Lymphoma
Dana-Farber Cancer Institute 13
Early research (Phase 1)Study completedNCT05216835
What this trial is testing

Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory Classical Hodgkin Lymphoma
AstraZeneca 45
Testing effectiveness (Phase 2)Study completedNCT02191930
What this trial is testing

Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Cologne 70
Not applicableStudy completedNCT02815137
What this trial is testing

Detection and Prognostic Value of Recurrent XPO1 Mutations of Patients With Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Centre Henri Becquerel 137
Testing effectiveness (Phase 2)Active Not RecruitingNCT03407144
What this trial is testing

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

Who this might be right for
Hodgkin Lymphoma
Merck Sharp & Dohme LLC 340
Testing effectiveness (Phase 2)WithdrawnNCT04138875
What this trial is testing

A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)

Who this might be right for
PTLDLymphoid TumorHematopoietic/Lymphoid Cancer+6 more
Yale University
Not applicableLooking for participantsNCT03280394
What this trial is testing

Liquid Biopsy in Mature B-cell Tumors

Who this might be right for
Mature B-Cell Neoplasm
Oncology Institute of Southern Switzerland 444
Testing effectiveness (Phase 2)Study completedNCT01022996
What this trial is testing

Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.

Who this might be right for
Hodgkin Lymphoma
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)Study completedNCT03331341
What this trial is testing

Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
University of Washington 50
Not applicableUnknownNCT03552003
What this trial is testing

Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis

Who this might be right for
Classical Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 400
Early research (Phase 1)Study completedNCT01561911
What this trial is testing

A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment

Who this might be right for
CancerNeoplasmsLymphoma+2 more
Cancer Research UK 29
Load More Results